Therapeutic development of novel orally-bioavailable small molecules to treat muscular dystrophies and sarcopenia

Project: Other project

Project Details

StatusFinished
Effective start/end date12/1/17 → 6/1/19

Funding

  • Sanofi US Services Inc: $112,500.00